For the year ending 2025-12-31, ACAD has $1,564,195K in assets. $336,805K in debts. $177,695K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 177,695 | |||
| Investment securities, available-for-sale | 641,991 | |||
| Accounts receivable, net | 121,457 | |||
| Interest and other receivables | 26,774 | |||
| Inventory | 34,670 | |||
| Prepaid expenses | 59,526 | |||
| Total current assets | 1,062,113 | |||
| Property and equipment, gross | 16,995 | |||
| Accumulated depreciation | 9,484 | |||
| Property and equipment, net | 7,511 | |||
| Operating lease right-of-use assets | 47,354 | |||
| Intangible assets, net | 108,893 | |||
| Restricted cash | 7,845 | |||
| Long-term inventory | 76,704 | |||
| Deferred tax assets | 249,879 | |||
| Other assets | 3,896 | |||
| Total assets | 1,564,195 | |||
| Accounts payable | 10,903 | |||
| Accrued liabilities | 266,211 | |||
| Total current liabilities | 277,114 | |||
| Operating lease liabilities | 40,554 | |||
| Other long-term liabilities | 19,137 | |||
| Total liabilities | 336,805 | |||
| Common stock, 0.0001 par value 225,000,000 shares authorized at december 31, 2025 and 2024 170,309,376 shares and 166,708,856 shares issued and outstanding at december 31, 2025 and 2024, respectively | 16 | |||
| Additional paid-in capital | 3,039,315 | |||
| Accumulated deficit | -1,813,386 | |||
| Accumulated other comprehensive income | 1,445 | |||
| Total stockholders equity | 1,227,390 | |||
| Total liabilities and stockholders equity | 1,564,195 | |||
ACADIA PHARMACEUTICALS INC (ACAD)
ACADIA PHARMACEUTICALS INC (ACAD)